High-risk human papillomavirus infection is associated with premature rupture of membranes

BMC Pregnancy and Childbirth

Volumn 13, Issue , 2013, Pages

  Cho, GeumJoon ^a   Min, Kyung Jin ^b   Hong, Hye Ri ^b   Kim, SuhngWook ^c   Hong, Jin Hwa ^a   Lee, Jae Kwan ^a   Oh, Min Jeong ^a   Kim, HaiJoong ^a  

^a Korea University College of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Korea University   (South Korea)

Author keywords

Complication; Human papillomavirus; Pregnancy

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; INCIDENCE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PREVALENCE; WART VIRUS; DIABETES, GESTATIONAL; FETAL MEMBRANES, PREMATURE RUPTURE; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTIONS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; SOUTH KOREA; VIROLOGY;

ADULT; BREAST NEOPLASMS; DNA, VIRAL; FEMALE; GENE DOSAGE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MEXICO; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, ESTROGEN; RECURRENCE; TUMOR BURDEN; CROSS-SECTIONAL STUDIES; DIABETES, GESTATIONAL; FETAL MEMBRANES, PREMATURE RUPTURE; INCIDENCE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; PREVALENCE; REPUBLIC OF KOREA;

EID: 84883508107     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-13-173     Document Type: Article

References (19)

1. Ministry of Health and Welfare 2002 Annual report of the Korea central cancer registry 2003, Seoul: Ministry of Health and Welfare, Ministry of Health and Welfare.
2. Fife KH, Katz BP, Roush J, Handy VD, Brown DR, Hansell R. Cancer-associated human papillomavirus types are selectively increased in the cervix of women in the first trimester of pregnancy. Am J Obstet Gynecol 1996, 174(5):1487-1493. 10.1016/S0002-9378(96)70593-8, 9065116.
3. Hermonat PL, Han L, Wendel PJ, Quirk JG, Stern S, Lowery CL, Rechtin TM. Human papillomavirus is more prevalent in first trimester spontaneously aborted products of conception compared to elective specimens. Virus Genes 1997, 14(1):13-17. 10.1023/A:1007975005433, 9208451.
4. Gomez LM, Ma Y, Ho C, McGrath CM, Nelson DB, Parry S. Placental infection with human papillomavirus is associated with spontaneous preterm delivery. Hum Reprod 2008, 23(3):709-715. 10.1093/humrep/dem404, 18184644.
5. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2006, 29(Suppl 1):S43-S48. American Diabetes Association.
6. Riedewald S, Kreutzmann IM, Heinze T, Saling E. Vaginal and cervical pH in normal pregnancy and pregnancy complicated by preterm labor. J Perinat Med 1990, 18(3):181-186. 10.1515/jpme.1990.18.3.181, 2384841.
7. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342(20):1500-1507. 10.1056/NEJM200005183422007, 10816189.
8. Ota A, Yonemoto H, Someya A, Itoh S, Kinoshita K, Nagaoka I. Changes in matrix metalloproteinase 2 activities in amniochorions during premature rupture of membranes. J Soc Gynecol Investig 2006, 13(8):592-597. 10.1016/j.jsgi.2006.10.001, 17178348.
9. Kato Y, Yamashita T, Ishikawa M. Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells. Oncol Rep 2002, 9(3):565-569.
10. da Silva Cardeal LB, Brohem CA, Correa TC, Winnischofer SM, Nakano F, Boccardo E, Villa LL, Sogayar MC, Maria-Engler SS. Higher expression and activity of metalloproteinases in human cervical carcinoma cell lines is associated with HPV presence. Biochem Cell Biol 2006, 84(5):713-719. 10.1139/o06-084, 17167534.
11. McLaren J, Malak TM, Bell SC. Structural characteristics of term human fetal membranes prior to labour: identification of an area of altered morphology overlying the cervix. Hum Reprod 1999, 14(1):237-241. 10.1093/humrep/14.1.237, 10374127.
12. Watts DH, Fazzari M, Minkoff H, Hillier SL, Sha B, Glesby M, Levine AM, Burk R, Palefsky JM, Moxley M, et al. Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected women. J Infect Dis 2005, 191(7):1129-1139. 10.1086/427777, 15747249.
13. Lukic A, Canzio C, Patella A, Giovagnoli M, Cipriani P, Frega A, Moscarini M. Determination of cervicovaginal microorganisms in women with abnormal cervical cytology: the role of Ureaplasma urealyticum. Anticancer Res 2006, 26(6C):4843-4849.
14. Goldenberg RL, Culhane JF. Infection as a cause of preterm birth. Clin Perinatol 2003, 30(4):677-700. 10.1016/S0095-5108(03)00110-6, 14714919.
15. Tenti P, Zappatore R, Migliora P, Spinillo A, Maccarini U, De Benedittis M, Vesentini N, Marchitelli G, Silini E, Carnevali L. Latent human papillomavirus infection in pregnant women at term: a case-control study. J Infect Dis 1997, 176(1):277-280. 10.1086/517266, 9207382.
16. Hernández-Girón C, Smith JS, Lorincz A, Lazcano E, Hernández-Avila M, Salmerón J. High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico. Sex Transm Dis 2005, 32(10):613-618. 10.1097/01.olq.0000179888.47309.db, 16205302.
17. Morrison EA, Gammon MD, Goldberg GL, Vermund SH, Burk RD. Pregnancy and cervical infection with human papillomaviruses. Int J Gynaecol Obstet 1996, 54(2):125-130. 10.1016/0020-7292(96)02694-X, 9236309.
18. Banura C, Franceschi S, van Doorn LJ, Arslan A, Kleter B, Wabwire-Mangen F, Mbidde EK, Quint W, Weiderpass E. Prevalence, incidence and clearance of human papillomavirus infection among young primiparous pregnant women in Kampala. Uganda. Int J Cancer 2008, 123(9):2180-2187.
19. Dare MR, Middleton P, Crowther CA, Flenady VJ, Varatharaju B. Planned early birth versus expectant management (waiting) for prelabour rupture of membranes at term (37 weeks or more). Cochrane database of systematic reviews 2006, 1. CD005302.